According to the Zhitong Finance App, Dongrui Pharmaceuticals (02348) announced that it will spend HK$3,840 to repurchase 4,000 shares on October 14, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.